LXEO   $6.83  -6.82% Market Closed After Close 6.3 -7.76%

Lexeo Therapeutics Inc
Total Cash 174.98M
totalCashPerShare 5.293
EBITDA -81.46M
Total Debt 10.85M
quickRatio 9.27
currentRatio 9.384
Total Revenue
debtToEquity 6.579
Revenue/Share
ROA -0.39933997
ROE -0.74834996
grossProfits
freeCashflow -36.83M
operatingCashflow -62.95M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 98.04M
forwardPE -2.8628159
floatShares 16.98M
sharesOutstanding 33.06M
sharesShort 2.06M
sharesShortPriorMonth 1.19M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.91%
Short Ratio help_outline 5.46%
shortPercentOfFloat 0.07%
impliedSharesOutstanding
bookValue 4.992
Price To Book help_outline 1.59
earningsQuarterlyGrowth
netIncomeToCommon -77.22M
trailingEps -12.53%
forwardEps -2.77%
enterpriseToEbitda -1.20
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.68 3Q 2024
institutionsCount 84
lastUpdated Nov. 2, 2024, 6:41 a.m.